AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 20795383
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group with basic therapy only
Trial: 20795383
Drug: Immunovac vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunovac vaccine
Trial: 18421050
Drug: Anthracycline (alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anthracycline (alone or in combination)
Trial: 10823095
Drug: Amethocaine patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amethocaine patch
Trial: 10823095
Drug: Ametop gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ametop gel
Trial: 10823095
Drug: Amethocaine patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amethocaine patch vs Ametop gel
Trial: 30663107
Drug: Tofacitinib 5
RxNorm normalized name: tofacitinib 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tofacitinib 5 mg b.d.
Trial: 28463028
Drug: 10 ml
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ml 1% lidocaine paracervical block
Trial: 28463028
Drug: 400 µg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 µg oral misoprostol
Trial: 27565425
Drug: C‐Mill therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C‐Mill therapy (therapy with augmented reality)
Trial: 27565425
Drug: FALLS program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FALLS program (a conventional therapy program)
Trial: 16255339
Drug: Sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate infusion (5 mEq/kg over 1 hour, followed by 5‐6 mEq/kg daily until recovery or death)
Trial: 16255339
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard treatment without high doses of sodium bicarbonate)
Trial: 7612060
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg ibuprofen racemate tid + placebo
Trial: 7266950
Drug: Intravenous ritodrine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ritodrine in a 0.1 wt/vol% solution of isotonic saline (N = 12)
Trial: 7266950
Drug: Intravenous ritodrine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ritodrine in isotonic glucose (N = 11)
Trial: 28292361
Drug: Per rectal
RxNorm normalized name: phenylephrine/pyrilamine/diper RECTAL OINTMENT (GRAM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Per rectal misoprostol (800 µgm)
Trial: 20187995
Drug: Pear-carrot-sea buckthorn
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pear-carrot-sea buckthorn (PCS) shots containing JA inulin (5 g/d)
Trial: 20187995
Drug: Plum-pear-beetroot (PPB)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plum-pear-beetroot (PPB) shots containing JA inulin (5 g/d)
Trial: 18550472
Drug: Biopsy diagnoses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biopsy diagnoses by clinical center (CC) pathologists
Trial: 12500511
Drug: Intravenous saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous saline 0.075 ml/kg (control)
Trial: 10036953
Drug: Lansoprazole (LPZ)
RxNorm normalized name: Lansoprazole
DrugBank: Lansoprazole (DB00448)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lansoprazole (LPZ) 30 mg, Clarithromycin (CAM) 400 mg, Metronidazole (MTZ) 500 mg (LCM group)
Trial: 10036953
Drug: Ranitidine (RNT)
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine (RNT) 300 mg, Clarithromycin (CAM) 400 mg, Metronidazole (MTZ) 500 mg (RCM group)
Trial: 2257961
Drug: 2% butoconazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% butoconazole nitrate cream used for 3 days
Trial: 2257961
Drug: 1% econazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% econazole nitrate cream used for 7 days
Trial: 7066167
Drug: Meladinine tablets
RxNorm normalized name: Melaniline
DrugBank: Diphenylguanidine (DB14191)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meladinine tablets (Basotherm)
Trial: 7066167
Drug: Oxsoralen capsules
RxNorm normalized name: Psoralen
DrugBank: Psoralen (DB18665)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxsoralen capsules (Elder)
Trial: 30431298
Drug: Light therapy
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Light therapy for 3 weeks
Trial: 26351345
Drug: Preoperative chemotherapy
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative chemotherapy with concurrent radiation therapy (RT)
Trial: 26351345
Drug: Preoperative chemotherapy
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative chemotherapy alone (without RT)
Trial: 21083673
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg of esomeprazole twice daily for 12 weeks
Trial: 15107193
Drug: Lisuride 0.2
RxNorm normalized name: lisuride 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisuride 0.2 mg
Trial: 11172176
Drug: Heptavalent pneumococcal
RxNorm normalized name: botulinum neurotoxin B immune FAB2
DrugBank: Equine Botulinum Neurotoxin B Immune FAB2 (DB13903)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heptavalent pneumococcal polysaccharide conjugate vaccine
Trial: 9629950
Drug: Citalopram infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram infusion (40 mg/day)
Trial: 9629950
Drug: Citalopram oral
RxNorm normalized name: citalopram Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram oral tablets (40 mg/day)
Trial: 31608532
Drug: Rikkunshito (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rikkunshito (2.5 g t.i.d. for 4 weeks)
Trial: 30246183
Drug: 5 mm
RxNorm normalized name: SUR-FIT 45 mm Wafer, Small
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mm long implants
Trial: 30246183
Drug: 11.5 mm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 11.5 mm long implants
Trial: 30246183
Drug: Short implants
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short implants (5 mm)
Trial: 30246183
Drug: Long implants
RxNorm normalized name: long pepper extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long implants (11.5 mm)
Trial: 21147907
Drug: 5-day zinc
RxNorm normalized name: zinc sulfate 5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-day zinc treatment
Trial: 21147907
Drug: 10-day zinc
RxNorm normalized name: zinc gluconate
DrugBank: Zinc gluconate (DB11248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 10-day zinc treatment
Trial: 12718838
Drug: Separate DTPw‐HBV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Separate DTPw‐HBV and Hib vaccines
Trial: 27130714
Drug: Broccoli sprouts
RxNorm normalized name: broccoli sprout extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Broccoli sprouts (BS) 100 g daily for 3 days
Trial: 27130714
Drug: Alfalfa sprouts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfalfa sprouts (AS) 100 g daily for 3 days (Control)
Trial: 22712582
Drug: Intraprostatic injection
RxNorm normalized name: ALCOHOL 80 mL in 100 mL INTRAPROSTATIC LIQUID [80% Alcohol Hand Sanitizer]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraprostatic injection of 200 U OnabotulinumtoxinA (BTX-A)
Trial: 21130386
Drug: CIC‐HFA 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CIC‐HFA 80 μg
Trial: 21130386
Drug: CIC‐HFA 160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CIC‐HFA 160 μg
Trial: 17034536
Drug: Topical methyl
RxNorm normalized name: methylal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical methyl aminolaevulinate (MAL)-photodynamic therapy (PDT)
Trial: 10914048
Drug: Diazepam premedication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam premedication (oral, 1 hour before BMP)
Trial: 10914048
Drug: Placebo premedication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo premedication (oral, 1 hour before BMP)
Trial: 8623975
Drug: Nalbuphine 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nalbuphine 2.5 mg/h, PSA nalbuphine 1 mg
Trial: 1564028
Drug: methylphenidate and
RxNorm normalized name: dexmethylphenidate and serdexmethylphenidate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: methylphenidate and lithium carbonate in combination
Trial: 3935644
Drug: Pelletized cromolyn
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pelletized cromolyn (cromolyn sodium, 20 mg)
Trial: 3935644
Drug: Cromolyn blend
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cromolyn blend (cromolyn sodium, 20 mg + lactose, 20 mg)
Trial: 31707149
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASA) 81 mg
Trial: 31707149
Drug: Esomeprazole (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole (40 mg) twice daily
Trial: 28222577
Drug: SUPP: 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SUPP: 500 mg alpha glycerophosphocholine [AGPC], 250 mg uridine‐5'‐monophosphate, and 1500 mg DHA
Trial: 24481133
Drug: Beetroot juice
RxNorm normalized name: tamarind juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beetroot juice supplementation (0.5 l/day organic beetroot juice containing about 5.5 mmol of NO₃⁻)
Trial: 20353024
Drug: Pinaverium bromide
RxNorm normalized name: pinaverium bromide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pinaverium bromide tablet (PVB)
Trial: 18959094
Drug: Diuretics (particularly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diuretics (particularly loop diuretics)
Trial: 18959094
Drug: Aldosterone antagonists
RxNorm normalized name: Aldosterone antagonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aldosterone antagonists (spironolactone and eplerenone)
Trial: 16087795
Drug: GM‐CSF (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GM‐CSF (10 microg/kg, subcutaneously applied for 14 days, total of 7 injections)
Trial: 7742149
Drug: Renin inhibitor
RxNorm normalized name: Renin inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Renin inhibitor
Trial: 1836569
Drug: Cefazolin or
RxNorm normalized name: Cefazolin
DrugBank: Cefazolin (DB01327)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefazolin or cefotaxime (3 doses of 1 g administered 8-hourly)
Trial: 1836569
Drug: Ceftriaxone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone (1 single dose of 1 g)
Trial: 6112844
Drug: Beta-blockers (general)
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blockers (general)
Trial: 21241214
Drug: Extended-dose nevirapine
RxNorm normalized name: nevirapine Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-dose nevirapine (ED-NVP)
Trial: 19119321
Drug: Single-dose nevirapine
RxNorm normalized name: Nevirapine
DrugBank: Nevirapine (DB00238)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single-dose nevirapine (SD-NVP)
Trial: 16890682
Drug: Uriston (P.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uriston (P. niruri extract) 2 gm daily for at least 3 months (group 1)
Trial: 14520089
Drug: No antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antibiotics for AOM
Trial: 14520089
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment for OME after untreated AOM
Trial: 14520089
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment for OME of unknown duration
Trial: 14520089
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment for chronic OME
Trial: 8406967
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no post space preparation)
Trial: 8406967
Drug: Post space
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post space preparation (both intervention groups)
Trial: 3534902
Drug: 3 X
RxNorm normalized name: Xenon (133 xe)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 X 60 mg Eburnamonine per day (n = 25)
Trial: 3534902
Drug: 1 X
RxNorm normalized name: Black Cohosh 1 X Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 X 60 mg Eburnamonine per day (n = 25)
Trial: 18846701
Drug: Plant sterol
RxNorm normalized name: plant sterol complex
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plant sterol (2.5 g/d)
Trial: 18846701
Drug: Plant stanol
RxNorm normalized name: plant stanol ester
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plant stanol (2.5 g/d)
Trial: 15914133
Drug: Three gels
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three gels containing different amounts of N-9 per dose
Trial: 12191837
Drug: 25 g
RxNorm normalized name: AndroGel 1.25 g Packets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 g of glucose administered immediately before presentation of a word list
Trial: 12191837
Drug: 25 g
RxNorm normalized name: AndroGel 1.25 g Packets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 g of glucose administered immediately after presentation of a word list
Trial: 12191837
Drug: 25 g
RxNorm normalized name: AndroGel 1.25 g Packets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 g of glucose administered 15 min before learning the word list
Trial: 2567265
Drug: SKF 94482
RxNorm normalized name: SKF-96365 free base
DrugBank: SKF-96365 free base (DB17054)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SKF 94482 200 mg at 07:30
Trial: 2567265
Drug: SKF 94482
RxNorm normalized name: SKF-96365 free base
DrugBank: SKF-96365 free base (DB17054)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SKF 94482 200 mg at 17:30
Trial: 2567265
Drug: SKF 94482
RxNorm normalized name: SKF-96365 free base
DrugBank: SKF-96365 free base (DB17054)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SKF 94482 200 mg at 21:30
Trial: 28718527
Drug: Intralesional Verapamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional Verapamil (10 mg in 5 mL of normal saline water) weekly for 12 weeks
Trial: 28718527
Drug: Intralesional Hyaluronic
RxNorm normalized name: hyaluronate
DrugBank: Hyaluronic acid (DB08818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intralesional Hyaluronic Acid (0.8% highly purified sodium salt HA 16 mg/2 mL) weekly for 12 weeks
Trial: 16820037
Drug: Bovine-derived xenograft
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bovine-derived xenograft (BDX) in combination with collagen membrane (BG)
Trial: 14559891
Drug: Aprepitant 375
RxNorm normalized name: Aprepitant
DrugBank: Aprepitant (DB00673)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aprepitant 375 mg before cisplatin and 250 mg on days 2 to 5 (n = 35)
Trial: 14559891
Drug: Aprepitant 125
RxNorm normalized name: aprepitant 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aprepitant 125 mg before cisplatin and 80 mg on days 2 to 5 (n = 81)
Trial: 10840297
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (10-day proton pump inhibitor-based triple therapy)
Trial: 10840297
Drug: Dual antibiotic
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual antibiotic therapy
Trial: 8466096
Drug: Cetirizine, 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetirizine, 10 mg, once daily (QD)
Trial: 8466096
Drug: Terfenadine, 60
RxNorm normalized name: Terfenadine, 60 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terfenadine, 60 mg, twice daily (BID)
Trial: 31801388
Drug: Prednisolone acetate
RxNorm normalized name: Prednisolone Acetate
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisolone acetate (10mg/ml)
Trial: 31801388
Drug: Nepafenac (1mg/ml)
RxNorm normalized name: Nepafenac
DrugBank: Nepafenac (DB06802)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nepafenac (1mg/ml)
Trial: 31801388
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (prednisolone acetate and nepafenac)
Trial: 26307570
Drug: CSL112 1.7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CSL112 1.7 g
Trial: 26307570
Drug: CSL112 3.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CSL112 3.4 g
Trial: 26307570
Drug: CSL112 6.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CSL112 6.8 g
Trial: 26307570
Drug: CSL112 (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CSL112 (all doses)
Trial: 20870337
Drug: High intensity
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High intensity cognitive therapy with nicotine replacement therapy (NRT)
Trial: 20870337
Drug: High intensity
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High intensity cognitive therapy without nicotine replacement therapy (NRT)
Trial: 19615208
Drug: Albumin administration
RxNorm normalized name: Albumin Aggregated
DrugBank: Albumin Aggregated (DB14230)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albumin administration (100 ml 20% human albumin daily for 3 days)
Trial: 19615208
Drug: Saline administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline administration (100 ml saline daily for 3 days)
Trial: 15175800
Drug: Argatroban (ARG)
RxNorm normalized name: Argatroban
DrugBank: Argatroban (DB00278)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Argatroban (ARG) at doses of 1.0, 2.0, or 3.0 microg/kg/min
Trial: 15175800
Drug: Argatroban (ARG)
RxNorm normalized name: Argatroban
DrugBank: Argatroban (DB00278)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Argatroban (ARG) at doses of 1.0, 2.0, or 3.0 microg/kg/min combined with VKA
Trial: 15175800
Drug: Argatroban (ARG)
RxNorm normalized name: Argatroban
DrugBank: Argatroban (DB00278)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Argatroban (ARG) at doses up to 2 microg/kg/min
Trial: 3556129
Drug: 24 mEq
RxNorm normalized name: sodium chloride 0.124 MEQ/ML Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24 mEq of Slow-K given as 8 mEq/tablet tid
Trial: 3556129
Drug: 30 mEq
RxNorm normalized name: Rum-K, 30 mEq/15 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mEq of K-Tab given as 10 mEq/tablet tid
Trial: 23643522
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (40 mg/day)
Trial: 23643522
Drug: Zinc +
RxNorm normalized name: GNP Cal Mag Zinc + D Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc + ALA supplementation (2 g/day flaxseed oil)
Trial: 16537857
Drug: Bronchial hyperresponsiveness
RxNorm normalized name: Bronchitol
DrugBank: Mannitol (DB00742)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bronchial hyperresponsiveness (BHR) determined by methacholine challenge test with a provocative concentration producing a 20% fall in FEV(1) < or = 8 mg/mL.
Trial: 16537857
Drug: Current diagnosed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Current diagnosed asthma defined as previous physician‐diagnosed asthma and any asthma symptom within the past 12 months or currently receiving asthma medication.
Trial: 14678209
Drug: Patch testing
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patch testing with hydroxycitronellal plus sodium lauryl sulfate (SLS)
Trial: 14678209
Drug: Patch testing
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patch testing with hydroxycitronellal alone
Trial: 10802474
Drug: Antibiotic solution
DrugBank: Polymyxin B (DB00781)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antibiotic solution of neomycin and polymyxin B
Trial: 10802474
Drug: 10% providone‐iodine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% providone‐iodine solution
Trial: 10802474
Drug: Chlorhexidine gluconate
RxNorm normalized name: Chlorhexidine Gluconate
DrugBank: Chlorhexidine (DB00878)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorhexidine gluconate solution
Trial: 30724455
Drug: Lorcaserin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorcaserin treatment
Trial: 12170046
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg intravenous dexamethasone
Trial: 24400953
Drug: 6 mg
RxNorm normalized name: boron 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg oral dexamethasone
Trial: 24400953
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of 6 mg oral vs. 4 mg intravenous dexamethasone
Trial: 19002481
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin A injection (2-5 IU in 0.2-0.5 ml of saline)
Trial: 30285891
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment for IBS
Trial: 30285891
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine treatment for IBS
Trial: 22440275
Drug: VEGF Trap‐Eye
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VEGF Trap‐Eye 2 mg
Trial: 15970844
Drug: Low-dose hCG
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose hCG (200 IU intramuscular injection daily) after 100 mg CC
Trial: 15970844
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg CC